MXCT
MaxCyte Inc

446
Mkt Cap
$76.76M
Volume
1.26M
52W High
$4.21
52W Low
$0.6806
PE Ratio
-1.67
MXCT Fundamentals
Price
$0.7196
Prev Close
$0.7339
Open
$0.7339
50D MA
$1.28
Beta
1.41
Avg. Volume
877,818.00
EPS (Annual)
-$0.3916
P/B
0.43
Rev/Employee
$338,833.33
$299.72
Loading...
Loading...
News
all
press releases
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January
MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 3,881,689 shares, a growth of 55.1...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded MaxCyte from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·8d ago
News Placeholder
MaxCyte, Inc. (NASDAQ:MXCT) Given Average Recommendation of "Hold" by Brokerages
MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has received a consensus rating of "Hold" from the five research firms that are currently covering the stock, MarketBeat Ratings reports. One equities...
MarketBeat·10d ago
News Placeholder
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) have received an average rating of "Hold" from the five brokerages that are currently covering the stock, MarketBeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Brokerages
Shares of MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) have been assigned an average rating of "Hold" from the five ratings firms that are covering the firm, MarketBeat reports. One research analyst...
MarketBeat·2mo ago
News Placeholder
Mirabella Financial Services LLP Has $14.39 Million Stock Position in MaxCyte, Inc. $MXCT
Mirabella Financial Services LLP raised its position in MaxCyte, Inc. (NASDAQ:MXCT - Free Report) by 78.4% during the second quarter, according to the company in its most recent disclosure with the...
MarketBeat·2mo ago
News Placeholder
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of MaxCyte from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·3mo ago
News Placeholder
FY2025 EPS Estimates for MaxCyte Boosted by William Blair
MaxCyte, Inc. (NASDAQ:MXCT - Free Report) - Stock analysts at William Blair upped their FY2025 earnings per share estimates for MaxCyte in a report released on Thursday, November 13th. William Blair...
MarketBeat·3mo ago
News Placeholder
MaxCyte (NASDAQ:MXCT) Announces Quarterly Earnings Results
MaxCyte (NASDAQ:MXCT - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus...
MarketBeat·3mo ago
News Placeholder
Insights into MaxCyte's Upcoming Earnings
read more...
Benzinga·3mo ago
<
1
2
...
>

Latest MXCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.